Defining natural history: assessment of the ability of college students to aid in characterizing clinical progression of Niemann-Pick disease, type C.
PLoS One.
2011;6(10):e23666. doi: 10.1371/journal.pone.0023666. Epub 2011 Oct 3. PubMed PMID:
21984891; PubMed Central PMCID:
PMC3184943.
Influence of antigen receptor avidity, affinity, and specificity on genetically engineered T cells.
In:
Want E, Ascierto PA, Stroncek DF, editors.
Developments in T Cell Based Cancer
New York, NY: Springer; 2015. p.75-98.
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.
Cancer Immunol Immunother.
2016 Mar;65(3):293-304. doi: 10.1007/s00262-016-1800-2. Epub 2016 Feb 3. PubMed PMID:
26842125; PubMed Central PMCID:
PMC4887146.
How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.
Proc Natl Acad Sci U S A.
2016 Mar 1;113(9):E1276-85. doi: 10.1073/pnas.1522069113. Epub 2016 Feb 16. PubMed PMID:
26884163; PubMed Central PMCID:
PMC4780628.
Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes.
J Immunol Methods.
2016 May;432:95-101. doi: 10.1016/j.jim.2016.02.016. Epub 2016 Feb 18. PubMed PMID:
26906089; PubMed Central PMCID:
PMC4837003.
Strategies to genetically engineer T cells for cancer immunotherapy.
Cancer Immunol Immunother.
2016 Jun;65(6):631-49. doi: 10.1007/s00262-016-1842-5. Epub 2016 May 2. Review. PubMed PMID:
27138532; PubMed Central PMCID:
PMC5424608.
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instability.
J Leukoc Biol.
2016 Sep;100(3):545-57. doi: 10.1189/jlb.2A1215-561R. Epub 2016 Feb 26. PubMed PMID:
26921345; PubMed Central PMCID:
PMC4982612.
How an alloreactive T-cell receptor achieves peptide and MHC specificity.
Proc Natl Acad Sci U S A.
2017 Jun 13;114(24):E4792-E4801. doi: 10.1073/pnas.1700459114. Epub 2017 Jun 1. PubMed PMID:
28572406; PubMed Central PMCID:
PMC5474831.
HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive Transfer.
Mol Ther Oncolytics.
2017 Jun 16;5:105-115. doi: 10.1016/j.omto.2017.05.004. eCollection 2017 Jun 16. PubMed PMID:
28573185; PubMed Central PMCID:
PMC5447397.
Comparative exploration of multidimensional flow cytometry software: a model approach evaluating T cell polyfunctional behavior.
J Leukoc Biol.
2017 Aug;102(2):551-561. doi: 10.1189/jlb.6A0417-140R. Epub 2017 May 26. PubMed PMID:
28550117; PubMed Central PMCID:
PMC6608077.
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
Cancer Immunol Immunother.
2017 Nov;66(11):1411-1424. doi: 10.1007/s00262-017-2032-9. Epub 2017 Jun 20. PubMed PMID:
28634816; PubMed Central PMCID:
PMC5647210.
Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
Mol Ther.
2018 Apr 4;26(4):996-1007. doi: 10.1016/j.ymthe.2018.01.015. Epub 2018 Feb 2. PubMed PMID:
29503203; PubMed Central PMCID:
PMC6079370.
TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependence.
J Leukoc Biol.
2018 May;103(5):973-983. doi: 10.1002/JLB.5A0817-314R. Epub 2018 Jan 19. PubMed PMID:
29350789; PubMed Central PMCID:
PMC6133711.
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.
Cancer Immunol Immunother.
2019 Nov;68(11):1881-1889. doi: 10.1007/s00262-019-02401-0. Epub 2019 Oct 8. Review. PubMed PMID:
31595324; PubMed Central PMCID:
PMC11028285.
Wilm's Tumor.
In:
Ferri FF, editor.
Ferri's Clinical Advisor
2022 ed. Philadelphia, PA: Elsevier Health Sciences; 2021.
Red Cell Disorders.
In:
Tenney Soeiro R, Pete Devon E, editors.
Netter's Pediatrics
2 ed. Philadelphia, PA: Elsevier; 2022. Chapter 77; p.462-467.
Bone Neoplasms.
In:
Tenney Soeiro R, Pete Devon E, editors.
Netter's Pediatrics
Philadelphia, PA: Elsevier; 2022. Chapter 128; p.761-764.
What would you like to do?